Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19
Authors:
Open Access
- 27 January 2023
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 21 (5) , 1307-1321
Abstract
No abstract availableKeywords
Funding Information
- Elizabeth Blackwell Institute for Health Research, University of Bristol
- British Heart Foundation (PG/21/10760)
- British Heart Foundation (PG/17/62/33190)
- British Heart Foundation (SP/F/21/150023)
- British Heart Foundation (RG/15/16/31758)
- British Heart Foundation (FS/17/60/33474)
- British Heart Foundation (AA/18/1/34219)
- Wellcome Trust
This publication has 72 references indexed in Scilit:
- Redundant role of ASK1-mediated p38MAPK activation in human platelet functionCellular Signalling, 2020
- The ins and outs of endocytic trafficking in platelet functionsCurrent Opinion in Hematology, 2017
- The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated CalreticulinFrontiers in Endocrinology, 2017
- Regulating billions of blood platelets: glycans and beyondBlood, 2015
- The role of galectin-3 and galectin-3–binding protein in venous thrombosisBlood, 2015
- Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose DexamethasoneNew England Journal of Medicine, 2003
- Gene Ontology: tool for the unification of biologyNature Genetics, 2000
- Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit.1996
- Exposure of ligand-binding sites on platelet integrin αIIB/β3 by phosphorylation of the β3 subunitBiochemical Journal, 1996
- Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human plateletsBiochemical Journal, 1991